Art

J-GLOBAL ID：201902216351017076   Reference number：19S0533501

SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria

Author (8)： Chino, Yukihiro (Department of Membrane Transport and Biopharmaceutics, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University) ,  Chino, Yukihiro (Drug Safety and Pharmacokinetics Laboratories, Taisho Pharmaceutical Co., Ltd) ,  Nakanishi, Takeo (Department of Membrane Transport and Biopharmaceutics, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University) ,  Tamai, Ikumi (Department of Membrane Transport and Biopharmaceutics, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University) ,  Yamaguchi, Jun-Ichi (Drug Safety and Pharmacokinetics Laboratories, Taisho Pharmaceutical Co., Ltd) ,  Samukawa, Yoshishige (Development Management, Taisho Pharmaceutical Co., Ltd) ,  Nakai, Yasuhiro (Development Management, Taisho Pharmaceutical Co., Ltd) ,  Sakai, Soichi (Clinical Research, Taisho Pharmaceutical Co., Ltd)
Material： Biopharmaceutics and Drug Disposition
Volume： 35  Issue： 7  Page： 391-404  Publication year： 2014 
JST Material Number： SCOPUS  ISSN： 0142-2782  CODEN： BDDID 
Country of issue： United Kingdom (GBR)  Language： English (EN)

Terms in the title (1)： SGLT2